Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled trial of genicular nerve block versus intra-articular steroid injection for knee osteoarthritis
ACTRN12623001278628Phase 4Not yet recruiting
- Sponsor
- St George Hospital
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone, bupivacaine, methylprednisolone, lidocaine and sodium chloride in knee osteoarthritis (OA) (3 arms), sponsored by St George Hospital. Primary endpoint: Pain. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
betamethasonebupivacainemethylprednisolonelidocainesodium chloride
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12623001278628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623001278628.